Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children

European Journal of Pediatrics

Volumn 169, Issue 9, 2010, Pages 1119-1122

  Von Linstow, Marie Louise ^a   Pontoppidan, Peter Lotko ^a   Von König, Carl Heinz Wirsing ^b   Cherry, James D ^c   Hogh, Birthe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Institut für Hygiene und Laboratoriumsmedizin   (Germany)

^c MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Pertussis; Pertussis epidemiology; Pertussis IgA; Pertussis toxin

Indexed keywords

BACTERIUM ANTIBODY; HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ARTICLE; BLOOD; BORDETELLA PERTUSSIS; COHORT ANALYSIS; DENMARK; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; PERTUSSIS; VACCINATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; COHORT STUDIES; DENMARK; FEMALE; HEMAGGLUTININS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; PERTUSSIS TOXIN; PERTUSSIS VACCINE; VACCINATION; WHOOPING COUGH;

EID: 79952108350     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-010-1192-9     Document Type: Article

References (21)

1. Carlsson RM, Gustafsson L (2008) Ten year report. Pertussis surveillance in Sweden. Progress Report 1 October 1997-31 December 2007. Smittskyddsinstitutets rapportserie 2008; No. 4
2. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J (2005) Defining pertussis epidemiology clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 24:S25-S34 (Pubitemid 40676533)
3. Cherry JD, Heininger U (2009) Pertussis and other Bordetella infections. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan S (eds) Feigin & Cherry's textbook of pediatric infectious diseases, 6th edn. WB Saunders Co, Philadelphia, pp 1683-1706
4. Cherry JD, Olin P (1999) The science and fiction of pertussis vaccines. Pediatrics 104:1381-1383
5. Cherry JD (1997) Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J 16:S90-S96
6. Greco D, Salmaso S, Mastrantonio P et al (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 334:341-348
7. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334:349-355 (Pubitemid 26049587)
8. Hallander HO, Gustafsson L (2009) Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience. Expert Rev Vaccines 8:1303-1307
9. Hviid A, Stellfeld M, Andersen PH, Wohlfahrt J, Melbye M (2004) Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. Vaccine 22:3530-3534 (Pubitemid 39099630)
10. Le T, Cherry JD, Chang S-J et al (2004) Immune responses and antibody decay after immunization of adolescents and adults with an acelluar pertussis vaccine: The APERT Study. JID 190:535-544 (Pubitemid 38982093)
11. Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other bordetella subspecies. Clin Microbio Rev 18:326-382 (Pubitemid 40548297)
12. Stehr K, Cherry JD, Heininger U et al (1998) A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acelluar pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101:1-11 (Pubitemid 28030315)
13. Storsaeter J, Blackwelder WC, Hallander HO (1992) Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am J Dis Child 146:167-172
14. Storsaeter J, Hallander H, Farrington CP, Olin P, Möllby R, Miller E (1990) Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine 8:457-461 (Pubitemid 20332854)
15. Storsaeter J, Olin P (1992) Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 10:142-144
16. Tan T, Trindade E, Skowronski D (2005) Epidemiology of pertussis. Pediatr Infect Dis J 24:S10-S18 (Pubitemid 40676531)
17. Trollfors B, Taranger J, Lagergard T et al (1995) A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 333:1045-1050
18. Vincent JM, Cherry JD, Nauschuetz WF et al (2000) Prolonged afebrile nonproductive cough illnesses in American Soldiers in Korea: a serological search for causation. Clin Infect Dis 30:534-539 (Pubitemid 30205301)
19. von Linstow ML, Hogh M, Nordbo SA, Eugen-Olsen J, Koch A, Hogh B (2008) A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr 167:1125-1133
20. Wirsing von Konig CH, Gounis D, Laukamp S, Bogaerts H, Schmitt HJ (1999) Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis 18:341-345
21. World Health Organization (1991) World Health Organization Meeting on Case Definition of Pertussis, Geneva, January 10-11, 1991. MIM/EPI/PERT/9.1 Geneva, World Health Organization